28 related articles for article (PubMed ID: 1302216)
1. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma.
Mittal BB; Zimmer MA; Sathiaseelan V; Benson AB; Mittal RR; Dutta S; Rosen ST; Spies SM; Mettler JM; Groch MW
Cancer; 1996 Nov; 78(9):1861-70. PubMed ID: 8909304
[TBL] [Abstract][Full Text] [Related]
2. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
3. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
[TBL] [Abstract][Full Text] [Related]
4. Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.
Juweid M; Sharkey RM; Alavi A; Swayne LC; Herskovic T; Hanley D; Rubin AD; Pereira M; Goldenberg DM
J Nucl Med; 1997 Feb; 38(2):257-60. PubMed ID: 9025751
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of colonic and ovarian cancer with radioactive monoclonal antibodies against the CA l9-9 and CA 125 antigens].
Graef A; Romero MA; González M; Pierzo JA; Sosa R; Altamirano P
Gac Med Mex; 1992; 128(2):91-5. PubMed ID: 1302216
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
Schmiegel WH; Kalthoff H
Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
[No Abstract] [Full Text] [Related]
8. Management of patients with ovarian cancer using monoclonal antibodies.
Lastoria S; Panza N; Esposito G; Vergara E; Castelli L; Caracò C; Battista C; Pacilio G; Salvatore M
Biomed Pharmacother; 1992; 46(10):453-63. PubMed ID: 1306360
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeled monoclonal antibodies for the diagnosis and treatment of ovarian carcinoma.
Wahl RL
Front Radiat Ther Oncol; 1990; 24():228-39. PubMed ID: 2187760
[No Abstract] [Full Text] [Related]
10. [Radioimmunotherapy of malignant diseases. Value and prospects].
Mahé MA; Chatal JF
Presse Med; 1995 Jan; 24(1):35-8. PubMed ID: 7899334
[TBL] [Abstract][Full Text] [Related]
11. Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiation.
Buchsbaum DJ; Roberson PL
Recent Results Cancer Res; 1996; 141():9-18. PubMed ID: 8722417
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
